A novel oral rabies vaccine enhances the immunogenicity through increasing dendritic cells activation and germinal center formation by expressing U-OMP19 in a mouse model

References

• Fisher CR, Streicker DG, Schnell MJ. The spread and evolution of rabies virus: conquering new frontiers. Nat Rev Microbiol. 2018;16(4):241–255.
   PubMed Web of Science ®Google Scholar
• Fooks AR, Banyard AC, Horton DL, et al. Current status of rabies and prospects for elimination. Lancet. 2014;384(9951):1389–1399.
   PubMed Web of Science ®Google Scholar
• Hampson K, Coudeville L, Lembo T, et al. Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis. 2015;9(4):e0003709.
   Web of Science ®Google Scholar
• Vigilato MAN, Clavijo A, Knobl T, et al. Progress towards eliminating canine rabies: policies and perspectives from Latin America and the Caribbean. Philos Trans Royal Soc London Ser B, Biol Sci. 2013;368(1623):20120143–20120143.
   PubMed Web of Science ®Google Scholar
• Hu R, Tang Q, Tang J, et al. Rabies in China: an update. Vector Borne Zoonotic Dis (Larchmont, NY). 2009;9(1):1–12.
   Web of Science ®Google Scholar
• Abela-Ridder B. Rabies: 100 per cent fatal, 100 per cent preventable. Vet Rec. 2015;177(6):148–149.
   Web of Science ®Google Scholar
• Blackwood JC, Streicker DG, Altizer S, et al. Resolving the roles of immunity, pathogenesis, and immigration for rabies persistence in vampire bats. Proc Natl Acad Sci USA. 2013;110(51):20837–20842.
   PubMed Web of Science ®Google Scholar
• Tu C, Feng Y, Wang Y. Animal rabies in the People’s Republic of China. Rev Sci Tech. 2018;37(2):519–528.
   Web of Science ®Google Scholar
• Campos AAS, Dos Santos RN, Benavides JA, et al. Rabies surveillance in wild mammals in South of Brazil. Transbound Emerg Dis. 2020;67(2):906–913.
   Web of Science ®Google Scholar
• Benavides JA, Megid J, Campos A, et al. Using surveillance of animal bite patients to decipher potential risks of rabies exposure from domestic animals and wildlife in Brazil. Front Public Health. 2020;8:318.
   Web of Science ®Google Scholar
• Health O W. WHO expert consultation on rabies. second report. World Health Organ Tech Rep Ser. 2013;982:1–139.
   Web of Science ®Google Scholar
• Lafay F, Bénéjean J, Tuffereau C, et al. Vaccination against rabies: construction and characterization of SAG2, a double avirulent derivative of SADBern. Vaccine. 1994;12(4):317–320.
   Web of Science ®Google Scholar
• Orciari LA, Niezgoda M, Hanlon CA, et al. Rapid clearance of SAG-2 rabies virus from dogs after oral vaccination. Vaccine. 2001;19(31):4511–4518.
   Web of Science ®Google Scholar
• Cliquet F, Gurbuxani JP, Pradhan HK, et al. The safety and efficacy of the oral rabies vaccine SAG2 in Indian stray dogs. Vaccine. 2007;25(17):3409–3418.
   PubMed Web of Science ®Google Scholar
• Fekadu M, Nesby SL, Shaddock JH, et al. Immunogenicity, efficacy and safety of an oral rabies vaccine (SAG-2) in dogs. Vaccine. 1996;14(6):465–468.
   Web of Science ®Google Scholar
• Kieny MP, Lathe R, Drillien R, et al. Expression of rabies virus glycoprotein from a recombinant vaccinia virus. Nature. 1984;312(5990):163–166.
   PubMed Web of Science ®Google Scholar
• Robbins AH, Borden MD, Windmiller BS, et al. Prevention of the spread of rabies to wildlife by oral vaccination of raccoons in Massachusetts. J Am Vet Med Assoc. 1998;213(10):1407–1412.
   PubMed Web of Science ®Google Scholar
• Fearneyhough MG, Wilson PJ, Clark KA, et al. Results of an oral rabies vaccination program for coyotes. J Am Vet Med Assoc. 1998;212(4):498–502.
   Web of Science ®Google Scholar
• Stohr K, Meslin FM. Progress and setbacks in the oral immunisation of foxes against rabies in Europe. Vet Rec. 1996;139(2):32–35.
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Human vaccinia infection after contact with a raccoon rabies vaccine bait – Pennsylvania, 2009. MMWR Morb Mortal Wkly Rep. 2009;58(43):1204–1207.
   Google Scholar
• Zhou M, Zhang G, Ren G, et al. Recombinant rabies viruses expressing GM-CSF or flagellin are effective vaccines for both intramuscular and oral immunizations. PLoS One. 2013;8(5):e63384.
   Web of Science ®Google Scholar
• Black JG, Lawson KF. Further studies of sylvatic rabies in the fox (Vulpes vulpes). vaccination by the oral route. Can Vet J. 1973;14(9):206–211.
   Web of Science ®Google Scholar
• Baer GM, Broderson JR, Yager PA. Determination of the site of oral rabies vaccination. Am J Epidemiol. 1975;101(2):160–164.
   Web of Science ®Google Scholar
• Pasquevich KA, Estein SM, García Samartino C, et al. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection. Infect Immun. 2009;77(1):436–445.
   PubMed Web of Science ®Google Scholar
• Coria LM, Risso GS, Guaimas FF, et al. Oral co-administration of a bacterial protease inhibitor in the vaccine formulation increases antigen delivery at the intestinal epithelial barrier. J Control Release. 2019;293:158–171.
   Web of Science ®Google Scholar
• Ibanez AE, Coria LM, Carabajal MV, et al. A bacterial protease inhibitor protects antigens delivered in oral vaccines from digestion while triggering specific mucosal immune responses. J Control Release. 2015;220(Pt A):18–28.
   Web of Science ®Google Scholar
• Faber M, Faber ML, Papaneri A, et al. A single amino acid change in rabies virus glycoprotein increases virus spread and enhances virus pathogenicity. J Virol. 2005;79(22):14141–14148.
   PubMed Web of Science ®Google Scholar
• Wen Y, Wang H, Wu H, et al. Rabies virus expressing dendritic cell-activating molecules enhances the innate and adaptive immune response to vaccination. J Virol. 2011;85(4):1634–1644.
   Web of Science ®Google Scholar
• Inoue K, Shoji Y, Kurane I, et al. An improved method for recovering rabies virus from cloned cDNA. J Virol Methods. 2003;107(2):229–236.
   PubMed Web of Science ®Google Scholar
• Zhao L, Toriumi H, Kuang Y, et al. The roles of chemokines in rabies virus infection: overexpression may not always be beneficial. J Virol. 2009;83(22):11808–11818.
   Web of Science ®Google Scholar
• Risso GS, Carabajal MV, Bruno LA, et al. U-Omp19 from Brucella abortus is a useful adjuvant for vaccine formulations against Salmonella infection in mice. Front Immunol. 2017;8:171.
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang L, Zhou S, et al. Recombinant rabies virus expressing dog GM-CSF is an efficacious oral rabies vaccine for dogs. Oncotarget. 2015;6(36):38504–38516.
   PubMedGoogle Scholar
• Cliquet F, Aubert M, Sagné L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods. 1998;212(1):79–87.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li M, Zhou M, et al. A novel rabies vaccine expressing CXCL13 enhances humoral immunity by recruiting both T follicular helper and germinal center B cells. J Virol. 2017;91(3).
   Web of Science ®Google Scholar
• Hargreaves DC, Hyman PL, Lu TT, et al. A coordinated change in chemokine responsiveness guides plasma cell movements. J Exp Med. 2001;194(1):45–56.
   PubMed Web of Science ®Google Scholar
• Tokoyoda K, Hauser AE, Nakayama T, et al. Organization of immunological memory by bone marrow stroma. Nat Rev Immunol. 2010;10(3):193–200.
   PubMed Web of Science ®Google Scholar
• Monaco F, Franchi P, Lelli R. Studies on an inactivated vaccine against rabies virus in domestic animals. Dev Biol (Basel). 2006;125:233–239.
   PubMedGoogle Scholar
• Dorfmeier CL, Shen S, Tzvetkov EP, et al. Reinvestigating the role of IgM in rabies virus postexposure vaccination. J Virol. 2013;87(16):9217–9222.
   PubMed Web of Science ®Google Scholar
• Bartlett BL, Pellicane AJ, Tyring SK. Vaccine immunology. Dermatol Ther. 2009;22(2):104–109.
   PubMed Web of Science ®Google Scholar
• Crotty S. T follicular helper cell differentiation, function, and roles in disease. Immunity. 2014;41(4):529–542.
   PubMed Web of Science ®Google Scholar
• Hsu A, Tseng C, Barrat J, et al. Safety, efficacy and immunogenicity evaluation of the SAG2 oral rabies vaccine in Formosan ferret badgers. PloS One. 2017;12(10):e0184831.
   Web of Science ®Google Scholar
• Giambartolomei GH, Zwerdling A, Cassataro J, et al. Lipoproteins, not lipopolysaccharide, are the key mediators of the proinflammatory response elicited by heat-killed Brucella abortus. J Immunol. 2004;173(7):4635–4642.
   Web of Science ®Google Scholar
• Mähl P, Cliquet F, Guiot A, et al. Twenty year experience of the oral rabies vaccine SAG2 in wildlife: a global review. Vet Res. 2014;45(77).
   Google Scholar
• Guadalupe M, Sankaran S, George MD, et al. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection. J Virol. 2006;80(16):8236–8247.
   PubMed Web of Science ®Google Scholar
• Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis. 2008;197(5):714–720.
   PubMed Web of Science ®Google Scholar
• Sinzger C, Grefte A, Plachter B, et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol. 1995;76(Pt 4):741–750.
   PubMed Web of Science ®Google Scholar
• Shen L, Chen CY, Huang D, et al. Pathogenic events in a nonhuman primate model of oral poliovirus infection leading to paralytic poliomyelitis. J Virol. 2017;91(14).
   Web of Science ®Google Scholar
• Prestwood TR, May MM, Plummer EM, et al. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol. 2012;86(22):12138–12147.
   PubMed Web of Science ®Google Scholar
• Mebatsion T, Schnell MJ, Cox JH, et al. Highly stable expression of a foreign gene from rabies virus vectors. Proc Natl Acad Sci U S A. 1996;93(14):7310–7314.
   PubMed Web of Science ®Google Scholar
• Pei J, Huang F, Wu Q, et al. Codon optimization of G protein enhances rabies virus-induced humoral immunity. J Gen Virol. 2019;100(8):1222–1233.
   Web of Science ®Google Scholar
• Li J, Ertel A, Portocarrero C, et al. Postexposure treatment with the live-attenuated rabies virus (RV) vaccine TriGAS triggers the clearance of wild-type RV from the central nervous system (CNS) through the rapid induction of genes relevant to adaptive immunity in CNS tissues. J Virol. 2012;86(6):3200–3210.
   PubMed Web of Science ®Google Scholar